The Federal Trade Commission has sued CVS Caremark, Express Scripts and Optum Rx, alleging that they engage in "anticompetitive and unfair rebating practices" as it relates to insulin. One legal expert believes the FTC might win this legal battle.
Attend the Discovery Critical Care Innovation Incubator on February 22, 2025, in Orlando, Florida, and ignite impactful change! Designed to foster collaboration among leading minds across diverse disciplines, this event will explore emerging innovations, spark partnerships, and fuel inspiration. Register and find more details at sccm.org/innovation.
Dupixent, a Sanofi and Regeneron Pharmaceuticals drug, is now approved for chronic obstructive pulmonary disease (COPD), a progressive lung disease prevalent in smokers. It's the sixth FDA-approved indication for the blockbuster drug.
What will happen in the fall remains to be seen, but the pledge is facilitating an open dialogue within the senior care industry about the problems it's facing, along with some fresh thinking on potential solutions.
The Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) is considering certain changes to the current meningococcal vaccination schedule. Here's why the ACIP should scrap that proposal.
Dr. Timothy Showalter talks about how AI can be a powerful force in recommending treatment for cancer patients. He is Artera's chief medical officer and the company has built a digital pathology tool for prostate cancer patients.
No comments